Literature DB >> 16301174

Dissociation of corticothalamic and thalamocortical axon targeting by an EphA7-mediated mechanism.

Masaaki Torii1, Pat Levitt.   

Abstract

Molecular mechanisms generating the topographic organization of corticothalamic (CT) circuits, which comprise more than three-quarters of the synaptic inputs onto sensory relay neurons, and their interdependence with thalamocortical (TC) axon development are unknown. Using in utero electroporation-mediated gene transfer, we show that EphA7-mediated signaling on neocortical axons controls the within-nucleus topography of CT projections in the thalamus. Notably, CT axons that mis-express EphA7 do not shift the relative positioning of their pathway within the subcortical telencephalon (ST), indicating that they do not depend upon EphA7/ephrin-A signaling in the ST for establishing this topography. Moreover, mis-expression of cortical EphA7 results in disrupted topography of CT projections, but unchanged inter- and intra-areal topography of TC projections. Our results support a model in which EphA/ephrin-A signaling controls independently the precision with which CT and TC projections develop, yet is essential for establishing their topographic reciprocity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16301174     DOI: 10.1016/j.neuron.2005.09.021

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  39 in total

1.  EphA signaling impacts development of topographic connectivity in auditory corticofugal systems.

Authors:  Masaaki Torii; Troy A Hackett; Pasko Rakic; Pat Levitt; Daniel B Polley
Journal:  Cereb Cortex       Date:  2012-04-05       Impact factor: 5.357

Review 2.  'Til Eph do us part': intercellular signaling via Eph receptors and ephrin ligands guides cerebral cortical development from birth through maturation.

Authors:  Hilary A North; Meredith A Clifford; Maria J Donoghue
Journal:  Cereb Cortex       Date:  2012-06-28       Impact factor: 5.357

3.  L1 and CHL1 Cooperate in Thalamocortical Axon Targeting.

Authors:  Galina P Demyanenko; Priscila F Siesser; Amanda G Wright; Leann H Brennaman; Udo Bartsch; Melitta Schachner; Patricia F Maness
Journal:  Cereb Cortex       Date:  2010-06-24       Impact factor: 5.357

4.  Evidence for activity-dependent cortical wiring: formation of interhemispheric connections in neonatal mouse visual cortex requires projection neuron activity.

Authors:  Hidenobu Mizuno; Tomoo Hirano; Yoshiaki Tagawa
Journal:  J Neurosci       Date:  2007-06-20       Impact factor: 6.167

5.  Grading the thalamus: how can an 'Eph' be excellent?

Authors:  Colenso M Speer; Barbara Chapman
Journal:  Thalamus Relat Syst       Date:  2005-09

6.  Integration of neuronal clones in the radial cortical columns by EphA and ephrin-A signalling.

Authors:  Masaaki Torii; Kazue Hashimoto-Torii; Pat Levitt; Pasko Rakic
Journal:  Nature       Date:  2009-09-16       Impact factor: 49.962

7.  EphA7 regulates spiral ganglion innervation of cochlear hair cells.

Authors:  Young J Kim; Leena A Ibrahim; Sheng-Zhi Wang; Wei Yuan; Oleg V Evgrafov; James A Knowles; Kai Wang; Huizhong W Tao; Li I Zhang
Journal:  Dev Neurobiol       Date:  2015-07-27       Impact factor: 3.964

8.  NrCAM deletion causes topographic mistargeting of thalamocortical axons to the visual cortex and disrupts visual acuity.

Authors:  Galina P Demyanenko; Thorfinn T Riday; Tracy S Tran; Jasbir Dalal; Eli P Darnell; Leann H Brennaman; Takeshi Sakurai; Martin Grumet; Benjamin D Philpot; Patricia F Maness
Journal:  J Neurosci       Date:  2011-01-26       Impact factor: 6.167

9.  Specificity and sufficiency of EphB1 in driving the ipsilateral retinal projection.

Authors:  Timothy J Petros; Brikha R Shrestha; Carol Mason
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

10.  EphrinA5 protein distribution in the developing mouse brain.

Authors:  Claire Deschamps; Milena Morel; Thierry Janet; Guylène Page; Mohamed Jaber; Afsaneh Gaillard; Laetitia Prestoz
Journal:  BMC Neurosci       Date:  2010-08-25       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.